DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/c55c9b/transdermal_medici) has announced the addition of the "Transdermal Medicine Review and Outlook 2011" report to their offering.
This special report focuses on the market leaders for transdermal medicine as well as the products in development anticipated to head this area in the years to come. This compilation's prescription-product pipeline details the following information for each medicine: chemical or substance composition, intended indication, class of drug, clinical status, region of development, and the product developer/intended marketer. Pipeline status details preclinical development, Phase I, Phase I/II, Phase II, Phase II/III, Phase III, and awaiting approval. Regions of development include the United States, Europe, and Japan. A directory of transdermal medicine prescription-drug developers and marketers is included.
Additionally provided in this report is a listing of transdermal medical-device entries, sorted by device class, as well as a directory of medical-device companies associated with the transdermal field.
Transdermal delivery is used to administer drugs via the skin, which is the human body's largest organ. Transdermal drug delivery represents a promising alternative to oral, intravascular, subcutaneous and transmucosal routes. Administering medicine through gels, patches and creams is one of the most frequent and effective alternatives to oral delivery, the most common way to take a drug.
Key Topics Covered:
- Transdermal Medicine Market Overview
- Transdermal Medicine Companies Review
- Transdermal Medicine Rx Drug and Biologic Pipeline
- Awaiting Approval
- Phase III
- Phase II/III
- Phase II
- Phase I/II
- Phase I
- Preclinical
- Developers and Marketers for Transdermal Medicine Rx Drugs/Biologics
- Transdermal Medicine Devices
- Class I
- Class II
- Class III
- Unclassified
- Transdermal Medicine Device Companies
For more information visit http://www.researchandmarkets.com/research/c55c9b/transdermal_medici